Viewing Study NCT00349427


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-03-05 @ 1:17 AM
Study NCT ID: NCT00349427
Status: COMPLETED
Last Update Posted: 2012-06-04
First Post: 2006-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module